FR2514354A1 - Nouveaux derives de 5-aminoisoxazole et procedes de leur preparation - Google Patents

Nouveaux derives de 5-aminoisoxazole et procedes de leur preparation Download PDF

Info

Publication number
FR2514354A1
FR2514354A1 FR8216914A FR8216914A FR2514354A1 FR 2514354 A1 FR2514354 A1 FR 2514354A1 FR 8216914 A FR8216914 A FR 8216914A FR 8216914 A FR8216914 A FR 8216914A FR 2514354 A1 FR2514354 A1 FR 2514354A1
Authority
FR
France
Prior art keywords
group
methyl
lower alkyl
alkyl group
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR8216914A
Other languages
English (en)
French (fr)
Inventor
Tochiro Tatee
Shuji Kurashige
Shinji Ito
Hiroshi Miyazaki
Akira Shiozawa
Hiroshi Yamanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Publication of FR2514354A1 publication Critical patent/FR2514354A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8216914A 1981-10-09 1982-10-08 Nouveaux derives de 5-aminoisoxazole et procedes de leur preparation Withdrawn FR2514354A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56161206A JPS5862169A (ja) 1981-10-09 1981-10-09 新規な５−アミノイソオキサゾ−ル誘導体

Publications (1)

Publication Number Publication Date
FR2514354A1 true FR2514354A1 (fr) 1983-04-15

Family

ID=15730608

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8216914A Withdrawn FR2514354A1 (fr) 1981-10-09 1982-10-08 Nouveaux derives de 5-aminoisoxazole et procedes de leur preparation

Country Status (7)

Country Link
JP (1) JPS5862169A (es)
DE (1) DE3237149A1 (es)
ES (2) ES516787A0 (es)
FR (1) FR2514354A1 (es)
GB (1) GB2107710A (es)
IT (1) IT8223685A0 (es)
SE (1) SE8205583L (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338857A (en) * 1989-08-04 1994-08-16 Mitsui Toatsu Chemicals Incorporated Aminoketone derivatives of 1,2-oxazole and use thereof
JPH0625178B2 (ja) * 1989-08-04 1994-04-06 三井東圧化学株式会社 アミノケトン誘導体及びその用途
JPH04368375A (ja) * 1991-06-17 1992-12-21 Otsuka Pharmaceut Factory Inc イソオキサゾール誘導体
US6544982B1 (en) * 1999-10-29 2003-04-08 Merck & Co., Inc. Thrombin receptor antagonists

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068418A1 (en) * 1969-10-27 1971-08-27 Innothera Lab Sa 2-substd-5-amino isoxazole derivs

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068418A1 (en) * 1969-10-27 1971-08-27 Innothera Lab Sa 2-substd-5-amino isoxazole derivs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 90, no. 25, 18 juin 1979, pages 611-612, abrégé 203924k, Columbus, Ohio, US; J.P. TRIVEDI et al.: "Synthesis and pharmacology of 5-(N,N-(di-alkylamino)-acetamido)-3,4-dimethyl isoxazoles and N-(di-alkylamino)-acetyl-11-H-dibenz(b,e)azepine", & Indian J. Pharm. Sci. 1979, 41(1), 28-31 *

Also Published As

Publication number Publication date
SE8205583L (sv) 1983-04-10
ES8402278A1 (es) 1984-02-01
DE3237149A1 (de) 1983-04-21
ES526914A0 (es) 1985-04-01
ES516787A0 (es) 1984-02-01
JPS5862169A (ja) 1983-04-13
SE8205583D0 (sv) 1982-09-30
ES8504156A1 (es) 1985-04-01
GB2107710A (en) 1983-05-05
IT8223685A0 (it) 1982-10-08

Similar Documents

Publication Publication Date Title
EP0526348B1 (fr) Dérivés d'indoline portant une fonction amidique, leur préparation, les compositions pharmaceutiques en contenant
EP0205375B1 (fr) Amides dérivés de la quinoléine, procédés pour leur préparation et médicaments les contenant
EP0863897B1 (fr) Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one, utiles comme ligands des recepteurs 5-ht4 ou h3
EP0373998B1 (fr) Ethers d'oxime de propénone, procédé pour leur préparation et compositions pharmaceutiques les contenant
FR2665898A1 (fr) Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0042781B1 (fr) Nouveaux dérivés de (quinolyl-4)-1 (pipéridyl ou pyrrolidinyl-2 ou -3)-2 ou -3 éthanone ou propanone, procédés pour leur préparation, et leur utilisation comme médicaments
JP2818958B2 (ja) ４―（４―アルコキシフェニル）―２―ブチルアミン誘導体およびその製造法
EP0360685B1 (fr) "[(diarylméthoxy) alcoyl] - 1 pyrrolidines et piperidines, procédés de préparation et médicaments les contenant"
CA2055326A1 (fr) Derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA1161849A (en) Derivatives of indole active on the cardiovascular system
FR2679555A1 (fr) Nouveaux derives de l'uree, leur preparation et leur application en therapeutique.
FR2659323A1 (fr) Derives de 4-(aminomethyl) piperidine, leur preparation et leur application en therapeutique.
EP0348257A2 (fr) Nouveaux dérivés d'(hétéro)aryl diazole, leur procédé de préparation et leur application en thérapeutique
FR2514354A1 (fr) Nouveaux derives de 5-aminoisoxazole et procedes de leur preparation
EP0053964B1 (fr) Médicaments à base de dérivés de (quinolyl-4)-1 éthanol ou propanol, nouveaux dérivés de (quinolyl-4)-1 éthanol ou propanol et procédés pour leur préparation
EP0110755A1 (fr) Dérivés de la pipéridinedione protecteurs du myocarde présentant une activité antiarythmique, leur procédé de préparation et les médicaments qui contiennent lesdits dérivés
CA1209995A (fr) Procede pour la preparation de composes de nicotinamide 1-oxyde n-substitue et de ses sels, et les composes et sels ainsi obtenus
FR2615188A1 (fr) Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant
EP0100257B1 (fr) Nouveaux dérivés aminoalkyl naphtaléniques, leurs sels d'addition d'acide et le procédé de préparation ainsi que l'application en thérapeutique de ces dérivés et sels
EP0002401B1 (fr) Dérivés de naphtalène, leur préparation et leur application en thérapeutique
EP0351283A1 (fr) Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique
EP0054593B1 (fr) Dérivés du pyrrole protecteurs du myocarde ayant une activité antiarythmique et antiagrégante plaquettaire, leur procédé de préparation et les médicaments en contenant
EP1140841B1 (fr) Derives de 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide et leur procede de preparation
FR2586417A1 (fr) Composes heterocycliques, leur preparation et composition pharmaceutique
EP0534856A1 (fr) Ethers d'oximes de thiénocyclopentanones, leur préparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse